Trials / Completed
CompletedNCT00062673
Study of Duloxetine in Elderly Patients With Major Depressive Disorder
Duloxetine Versus Placebo in the Treatment of Elderly Patients With Major Depressive Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 311 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
A study of the safety and efficacy of duloxetine in elderly patients (greater than 65 years old) with major depressive disorder
Detailed description
Duloxetine 60 mg QD and placebo variable-duration, placebo lead-in period 9 weeks in the acute treatment phase
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | |
| DRUG | Placebo |
Timeline
- Start date
- 2003-03-01
- Completion
- 2004-07-01
- First posted
- 2003-06-12
- Last updated
- 2007-05-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00062673. Inclusion in this directory is not an endorsement.